NCT06424015 - Insulin and Insulin Pulses During Fasting | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 15, 2024

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2027

Conditions

PreDiabetes

Interventions

OTHER

Intralipid and heparin

Intralipid (20%, 0.011ml/kg/min; Baxter, Healthcare, Deerfield, IL) and heparin (200 units prime, 0.2 unit/kg/min continuous) will be infused to induce acute insulin resistance

OTHER

Saline

Saline will be infused

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester